Skip to main content
Toggle navigation
Search
Home
Infectious Diseases (INF)
Home
Infectious Diseases (INF)
Infectious Diseases (INF)
Type here to filter the list
PI-017 - CONCENTRATION-RESPONSE RELATIONSHIP OF MAM01, AN INVESTIGATIONAL MONOCLONAL ANTIBODY TARGETING THE CIRCUMSPOROZOITE PROTEIN (CSP), IN A CONTROLLED HUMAN INFECTION MODEL (CHIM) STUDY.
Favorite
PI-018 - INTERPLAY BETWEEN HIV AND METHADONE: EFFECTS ON CHEMOKINE DYSREGULATION AND NEUROINFLAMMATION.
Favorite
PI-019 - LOW POTENTIAL FOR DRUG INTERACTION BETWEEN LENACAPAVIR AND FENTANYL.
Favorite
PI-020 - PREDICTING OPTIMAL PATIENT-CENTRIC TREATMENT DURATION FOR LEVOFLOXACIN-CONTAINING TUBERCULOSIS REGIMEN: AN INTEGRATED APPROACH OF A MODEL-BASED STRATIFICATION TOOL WITH SITE-OF-DISEASE PHARMACOLOGY KNOWLEDGE
Favorite
PI-021 - THE EFFECTS OF OPIOIDS ON BLOOD-BRAIN BARRIER INTEGRITY, ANTIRETROVIRAL ACCUMULATION, AND NEUROINFLAMMATORY CHEMOKINE PROFILES IN ECOHIV-INFECTED MICE
Favorite
PII-016 - CHARACTERIZATION AND PHARMACOKINETIC MODELLING OF VANCOMYCIN IN CRITICALLY ILL ICU PATIENTS UNDERGOING CVVHD
Favorite
PII-017 - EFFECTS OF HIV AND OPIOIDS ON CHEMOKINE EXPRESSION IN AN INFECTIOUS MOUSE MODEL
Favorite
PII-018 - INTESTINAL MICROBIOME AND METABOLOME FLUCTUATIONS IN PATIENTS RECEIVING INTENSE CHEMOTHERAPY FOR AML: RESULTS FROM A PILOT, PROSPECTIVE OBSERVATIONAL STUDY
Favorite
PII-019 - POPULATION PHARMACOKINETICS OF DELAMANID AND ITS METABOLITE DM-6705 IN MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS RECEIVING NOVEL SHORT-COURSE ORAL REGIMENS IN THE ENDTB AND ENDTB-Q TRIALS
Favorite
PII-020 - SIMILAR BIOAVAILABILITY OF SUBCUTANEOUS BEPIROVIRSEN WHEN DELIVERED FROM A VIAL OR PREFILLED SYRINGE FITTED WITH A SAFETY SYRINGE DEVICE IN HEALTHY ADULT PARTICIPANTS
Favorite
PII-021 - VIRAL VANGUARD: TURNING THE TIDE AGAINST SUPERBUGS
Favorite